NCT02652910 - Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions

Recurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell LymphomaStage III Adult Diffuse Large Cell LymphomaStage III Follicular LymphomaStage III Mantle Cell LymphomaStage IV Adult Diffuse Large Cell LymphomaStage IV Follicular LymphomaStage IV Mantle Cell Lymphoma

Interventions

DRUG

CD19.CAR-T cells

Retroviral vector-transduced autologous T cells to express CD19-specific CARs

Trial Locations (1)

400000

RECRUITING

Department of Oncology, Chongqing